Published in Cancer Epidemiol Biomarkers Prev on August 27, 2010
Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study. BMJ (2016) 1.39
Progesterone action in breast, uterine, and ovarian cancers. J Mol Endocrinol (2015) 0.98
Breast Cancer Research in the Nurses' Health Studies: Exposures Across the Life Course. Am J Public Health (2016) 0.96
Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev (2014) 0.92
Tracking progesterone receptor-mediated actions in breast cancer. Pharmacol Ther (2013) 0.91
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia (2013) 0.90
Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study. Hum Reprod (2011) 0.86
Oral contraceptive formulation and risk of breast cancer. Contraception (2011) 0.85
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. Oncotarget (2014) 0.84
Estrogen receptor positive breast cancers and their association with environmental factors. Int J Health Geogr (2011) 0.83
A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Res (2015) 0.82
A prospective study of oral contraceptive use and colorectal adenomas. Cancer Causes Control (2016) 0.81
Caffeinated beverage and soda consumption and time to pregnancy. Epidemiology (2012) 0.81
Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res (2014) 0.81
Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study. BMJ (2014) 0.81
Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer. Am J Epidemiol (2016) 0.78
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer. PLoS One (2016) 0.78
Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception (2012) 0.77
Investigation on the association between breast cancer and consumption patterns of combined oral contraceptive pills in the women of Isfahan in 2011. Iran J Nurs Midwifery Res (2013) 0.77
Breast cancer risk factors. Prz Menopauzalny (2015) 0.76
Risk factors for breast cancer in China: similarities and differences with western populations. Arch Med Sci (2012) 0.76
The breast cancer epidemic: 10 facts. Linacre Q (2014) 0.76
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Mol Cancer Res (2015) 0.76
Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study. Am J Public Health (2016) 0.75
Knowledge, awareness, and perception of contraception among senior pharmacy students in Malaysia: A pilot study. J Res Pharm Pract (2015) 0.75
The molecular landscape of the normal human breast--defining normal. Breast Cancer Res (2014) 0.75
The incidence of breast cancer in population of young women from Podkarpackie province in 2002-2011. Contemp Oncol (Pozn) (2016) 0.75
Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model. Maturitas (2016) 0.75
Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review. J Genet Couns (2017) 0.75
Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk. Front Oncol (2017) 0.75
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst (2002) 9.65
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA (2000) 7.77
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol (2000) 3.94
Meta-analysis of epidemiologic dose-response data. Epidemiology (1993) 2.54
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception (1996) 2.02
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol (2008) 1.72
Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception (1997) 1.60
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev (2002) 1.54
Oral contraceptives and breast cancer. Review and meta-analysis. Cancer (1990) 1.21
Oral contraceptive use influences resting breast proliferation. Hum Pathol (1989) 1.20
Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids (2000) 1.14
Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer (2003) 1.07
Good news about oral contraceptives. N Engl J Med (2002) 1.06
Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol (1997) 1.03
Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol (2007) 0.99
Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst (1989) 0.99
Sex steroids and breast cancer prevention. J Natl Cancer Inst Monogr (1994) 0.98
Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives. Am J Obstet Gynecol (1994) 0.97
Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat (2001) 0.95
Effect of combined oral contraceptives on breast epithelial proliferation in young women. Breast J (2008) 0.92
Relative potency of progestins used in oral contraceptives. Contraception (1985) 0.91
A comparison of the potencies and activities of progestogens used in contraceptives. Contraception (1987) 0.90
Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. Cancer Epidemiol Biomarkers Prev (2007) 0.89
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol (2005) 17.45
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41
Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med (2004) 5.68
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63
Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60
Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59
Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34
Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72
Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62
A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48
Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46
Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36